Dulaglutide vs Liraglutide
Last updated
Compare the ingredients, then check the specific brand, formulation, and dose. Approved uses and prices vary by product.
Dulaglutide vs Liraglutide: lowest prices now
| Compare | Dulaglutide | Liraglutide |
|---|---|---|
| What it is for | FDA-approved for
| FDA-approved for
|
| Brands | Trulicity GLP-1 | Victoza, Saxenda GLP-1 |
| Route & frequency | Subcutaneous injection Once weekly | Subcutaneous injection Once daily |
| FDA shortage report | National reporting does not confirm stock at your pharmacy. Coverage & source records |
Direct comparative evidence
No direct comparative trial is included for these ingredients in our reviewed catalog. The separate trial results below do not establish which works better.
What the quoted price covers
Lowest tracked quotes for FDA-approved products, selected separately for each price basis. Entry prices may refer to different brands or formulations. Supply periods, eligibility, refill deadlines, and additional fees can change what you pay.
| Compare | Dulaglutide | Liraglutide |
|---|---|---|
| Advertised entry price | from $389/28 days (lilly.com/lillydirect/trulicity) Trulicity single-dose pens LillyDirect (Eli Lilly) self-pay, four weekly pens; published starting rate at each dose 28-day supply (lilly.com) ≈ $416.79 per 30 days at this quoted rate Checked on lilly.com Price conditionsself-pay, four weekly pens; published starting rate at each dose The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days. 28-day supply | from $349/mo (healifynow.com/saxenda) Saxenda via HealifyNow HealifyNow its Saxenda page says "From $349/month" for Saxenda (liraglutide 3 mg, weight management), and "Your first consultation is free. No insurance needed, and you only pay if you start treatment." On the same page, "Can I cancel my Saxenda plan at any time?" is answered "Yes. There are no contracts, and you can cancel from your patient portal." Billed per month; days of supply not on record, so ordered as four weekly doses. Checked on healifynow.com Price conditionsits Saxenda page says "From $349/month" for Saxenda (liraglutide 3 mg, weight management), and "Your first consultation is free. No insurance needed, and you only pay if you start treatment." On the same page, "Can I cancel my Saxenda plan at any time?" is answered "Yes. There are no contracts, and you can cancel from your patient portal." A starting price: the page does not say what the figure includes or how it changes with the dose; the page prices it per month with no contracts. Its pages also list "Liraglutide From $149/mo" without saying which kind of liraglutide it is. FDA-approved product. |
| At the named trial dose | from $389/28 days (lilly.com/lillydirect/trulicity) Trulicity single-dose pens At 4.5 mg LillyDirect (Eli Lilly) Published price at 4.5 mg 28-day supply (lilly.com) ≈ $416.79 per 30 days at this quoted rate Checked on lilly.com Price conditionsPublished price at 4.5 mg The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days. The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply. 28-day supply | ~$372/mo (goodrx.com/liraglutide-saxenda) Generic liraglutide 3 mg pens (Saxenda generic), GoodRx coupon At 3 mg GoodRx Published price at 3 mg Third-party reported price30-day supply (dailymed.nlm.nih.gov) $372.45 per 30 days at this quoted rate Checked on goodrx.com Price conditionsPublished price at 3 mg GoodRx lists this liraglutide (Saxenda) only as a generic; its price is for one carton of five 18 mg/3 mL pens. Prices vary by pharmacy. Five pens hold 90 mg: 30 days at the 3 mg daily dose. 30-day supply |
| Every offer | All 5 offersAll 5 dulaglutide offers | All 29 offersAll 29 liraglutide offers |
USD self-pay, not insurance or pharmacy acquisition cost. A trial dose is not a personal dosing recommendation. Compounded offers are shown separately in the offer browser and are not FDA-approved.
Trial outcomes in context
Each result belongs to its own trial, population, dose, and analysis. Weight loss, HbA1c change, and adverse events may come from different studies even within one ingredient. These are study averages, not predictions of your result.
| Compare | Dulaglutide | Liraglutide |
|---|---|---|
| Weight change | ≈−4.8% (diabetesjournals.org/care/article/44/3/765/138650) (-4.6 kg (~4.8% of the 95.4 kg baseline) at 36 wks · AWARD-11 · 4.5 mg weekly (Trulicity)) -4.6 kg (~4.8% of the 95.4 kg baseline) at 36 wks AWARD-11 (diabetesjournals.org)4.5 mg weekly (Trulicity) Approximation from kilograms; see trial methods Study contextA diabetes trial; weight loss is a secondary endpoint, so the effect is modest. | −8% (nejm.org/doi/full/10.1056/NEJMoa1411892) (-8.0% at 56 wks · SCALE Obesity · 3.0 mg daily (Saxenda)) -8.0% at 56 wks SCALE Obesity (nejm.org)3.0 mg daily (Saxenda) Analysis not classified; see trial methods |
| HbA1c change (percentage points) | −1.9 pp (diabetesjournals.org/care/article/44/3/765/138650) (-1.9% at 36 wks · AWARD-11 · HbA1c change in percentage points) -1.9 percentage points at 36 wks AWARD-11 (diabetesjournals.org) | −1.3 pp (doi.org/10.1001/jama.2015.9676) (-1.3% at 56 wks · SCALE Diabetes · HbA1c change in percentage points) -1.3 percentage points at 56 wks SCALE Diabetes (doi.org) |
| Adverse events | Stopped treatment for adverse events 8.5% (pmc.ncbi.nlm.nih.gov/articles/PMC7896253) (8.5% vs 6.0% on the 1.5 mg comparator (no placebo arm) · AWARD-11 (4.5 mg, type 2 diabetes))Reported nausea 17.3% (pmc.ncbi.nlm.nih.gov/articles/PMC7896253) (Nausea in the drug arm · AWARD-11 (4.5 mg, type 2 diabetes))AWARD-11 (4.5 mg, type 2 diabetes) a type 2 diabetes trial with no placebo arm (the contrast is vs dulaglutide 1.5 mg), so it is not one-to-one with the obesity-trial figures | Stopped treatment for adverse events 9.8% (accessdata.fda.gov/drugsatfda_docs/label/2014/206321orig1s000lbl.pdf) (9.8% vs 4.3% placebo (3.0 mg) · FDA Saxenda label, pooled 3.0 mg obesity trials (SCALE))Reported nausea 39.3% (accessdata.fda.gov/drugsatfda_docs/label/2014/206321orig1s000lbl.pdf) (Nausea in the drug arm · FDA Saxenda label, pooled 3.0 mg obesity trials (SCALE))FDA Saxenda label, pooled 3.0 mg obesity trials (SCALE) from the FDA Saxenda adverse-reactions table (the SCALE Obesity trial paper is paywalled); essentially identical to the trial's own ~9.9% / ~40% figures |
Timing, generics and coverage
Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.
| Brand | Soonest top dose | Half-life | Generic approved? | Patent on the medicine to | On Medicare Part D, 2025 |
|---|---|---|---|---|---|
| Victoza | 1.8 mg from week 3 | about 13 hours | Yes, 8 | None listed | 6,810 |
| Saxenda | 3 mg from week 5 | about 13 hours | Yes, 3 | None listed | None listed |
| Trulicity | 4.5 mg from week 13 | about 5 days | No, it is a biologic | Not in the Orange Book | 582,333 |
How long each takes · Generics and patents · Who covers what
Approved uses & full records
Dulaglutide
Indications depend on the brand and formulation. Read the product-specific indications and prescribing information in the full record.
145 registered ingredient studies (clinicaltrials.gov/search). Count checked . Research activity, not a measure of evidence quality.
Open full recordLiraglutide
Indications depend on the brand and formulation. Read the product-specific indications and prescribing information in the full record.
522 registered ingredient studies (clinicaltrials.gov/search). Count checked . Research activity, not a measure of evidence quality.
Open full recordCommon questions
Is Dulaglutide or Liraglutide better for weight loss?
No trial on our list compared them directly. In separate trials: Dulaglutide -4.6 kg (~4.8% of the 95.4 kg baseline) at 36 wks in AWARD-11 (4.5 mg weekly (Trulicity)) (diabetesjournals.org); Liraglutide -8.0% at 56 wks in SCALE Obesity (3.0 mg daily (Saxenda)) (nejm.org). Separate trials enrolled different people for different lengths of time, so these figures cannot rank them.
Is Dulaglutide or Liraglutide safer?
We know of no trial set up to answer that. Stopping because of side effects, each in its own trial and not a head-to-head figure: Dulaglutide 8.5% vs 6.0% on the 1.5 mg comparator (no placebo arm) (AWARD-11 (4.5 mg, type 2 diabetes)) (pmc.ncbi.nlm.nih.gov); Liraglutide 9.8% vs 4.3% placebo (3.0 mg) (FDA Saxenda label, pooled 3.0 mg obesity trials (SCALE)) (accessdata.fda.gov). Each FDA label lists its own warnings, and which ones matter depends on your health.
What Liraglutide dose is equivalent to Dulaglutide?
No FDA label sets a dose of Dulaglutide that equals a dose of Liraglutide, and we know of no trial that defines one. Switching is a prescriber's decision, and each label sets its own starting dose and steps.
Which costs less: Dulaglutide or Liraglutide?
Compare the named products and price conditions below. A tracked entry quote can be a different brand or formulation from the product studied in a trial. A trial-dose quote applies only to the named product and dose; neither figure is an estimate of your whole treatment cost or an insurance quote.
Do these trial results tell me which medication is best?
Direct trials compare the treatments, doses, and participants they studied. Results from separate trials differ in population, duration, dose, and analysis, so their percentages do not establish a treatment ranking. Discuss your medical history and the specific product label with a licensed clinician.
Does FDA shortage status mean my pharmacy has stock?
No. FDA shortage records describe national supply reports and covered presentations, not inventory at an individual pharmacy. Unknown status means the data cannot establish a current assessment. Confirm local stock with your pharmacy.
What changed for Dulaglutide and Liraglutide
- TrialResults posted for a Liraglutide study: SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity (clinicaltrials.gov/study/NCT04775082)
- PriceSingleCare: Trulicity pens (SingleCare coupon) now ranked per 30 days at about $914: ~$853 per 4 pens buys 28 days (dailymed.nlm.nih.gov/dailymed/drugInfo.cfm)
- PriceGoodRx: Trulicity (brand, all doses) now ~$992/mo (was ~$952/mo) (read on goodrx.com)
- FDA labelFDA label updated: Liraglutide (Lupin Pharmaceuticals, Inc.), effective 2026-10-30 (api.fda.gov/drug/label.json)
- FDA labelFDA label updated: liraglutide (Orbicular Pharmaceutical Technologies Private Limited), effective 2026-10-15 (api.fda.gov/drug/label.json)
- FDA labelFDA label updated: Liraglutide (Orbicular Pharmaceutical Technologies Private Limited), effective 2026-10-15 (api.fda.gov/drug/label.json)
Written from each source's own record as it changes. Every change on GLPcompare
Automated feed checks do not constitute a clinical or editorial review. Sources & methodology